Back
Day Range
$21.73
$22.72
52-Week Range
$15.47
$27.22
Volume
483,405
50D / 200D Avg
$22.89
/
$21.19
Prev Close
$22.02
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -5.9 | 0.4 |
| P/B | 3.2 | 2.9 |
| ROE % | -58.9 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -160.59M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-58.88%
ROIC-43.34%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio12.83
Interest Coverage0.00
Valuation
P/E Ratio
-5.90
P/B Ratio3.19
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -166.31M |
| ROE | -58.88% | ROA | -49.92% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -160.59M |
| ROIC | -43.34% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 12.83 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -5.90 | P/B Ratio | 3.19 |
| P/S Ratio | N/A | PEG Ratio | -0.07 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 980.39M | Enterprise Value | 934.87M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -166.31M | -80.49M | -69.33M | -36.91M | -51.61M |
| EPS (Diluted) | -4.32 | -2.56 | -2.17 | -1.10 | -40.44 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -177.53M | -94.31M | -74.59M | -36.91M | -8.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 333.17M | 274.94M | 163.10M | 182.83M | 43.04M |
| Total Liabilities | 25.95M | 17.29M | 11.80M | 8.37M | 1.82M |
| Shareholders' Equity | 307.22M | 257.65M | 151.30M | 174.46M | 41.22M |
| Total Debt | 14,000.0 | 176,000.0 | 317,000.0 | 139,000.0 | 0.0 |
| Cash & Equivalents | 45.54M | 74.29M | 150.39M | 163.37M | 37.28M |
| Current Assets | 332.90M | 226.98M | 159.97M | 182.62M | 42.95M |
| Current Liabilities | 25.95M | 17.27M | 11.62M | 8.36M | 1.82M |